Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions.

BACKGROUND Lesions that are histologically classified as precursors of cervical cancer, which are often referred to as squamous intraepithelial lesions (SILs), represent a heterogeneous clinical entity that can be associated with many different types of human papillomaviruses (HPVs) and have a variable biologic behavior. Approximately one half of low-grade SILs behave as non-neoplastic, productive viral lesions that frequently regress spontaneously, whereas the other half behave as neoplasms and either persist or progress to a histologically higher grade lesion. Identification of biomarkers that reliably differentiate those low-grade SILs with the properties of a non-neoplastic viral infection from those with the properties of neoplasia would provide a more rational basis for decisions about disease management. Since monoclonality is a hallmark of neoplasia irrespective or organ site, clonal status might represent one such biomarker. PURPOSE To better understand the pathobiology of SILs, we analyzed the clonality of low-grade and high-grade SILs and compared their clonal status with their associated HPV types. METHODS One hundred forty formalin-fixed, paraffin-embedded cervical biospy and loop electrosurgical specimens, originally diagnosed as SILs, were obtained from the pathology archives of both the Columbia-Presbyterian Medical Center and Kyto Diagnostics in New York. Clonality was determined with the use of a polymerase chain reaction (PCR) based method that detects nonrandom X-chromosome inactivation. This PCR-method amplifies a polymorphic region of the androgen receptor gene that is flanked by several differentially methylated enzyme sites. The same tissue was also analyzed for HPV DNA with the use of PCR and both L1 and E6 "consensus" primers. RESULTS All 25 evaluable cases of high-grade SILs were determined to be monoclonal. Although 54 (68%) of 79 evaluable low-grade SILs were monoclonal, 25 (32%) of 79 low-grade SILs were polyclonal. A strong association was observed between HPV type and clonal status, with a total of 71 (47 low-grade and 24 high-grade) SILs determined to be monoclonal and containing HPV types 16, 18, 31, 33, 35, 39, 45, 56, 58, or 65. In contrast, 22 (92%) of the 24 low-grade SILs that contained another type of HPV were polyclonal (Fisher's exact test, two-sided, P</-.001). CONCLUSIONS Our findings suggest that the histopathologic entity termed low-grade SIL consists of two different types of lesions that are biologically distinct. One lesion is monoclonal and is associated with HPV types 16, 18, 31, 33, 35, 39, 45, 56, 58, or 65. The second types of low-grade SIL is polyclonal and is associated with other types of HPV.

[1]  M. Schiffman,et al.  Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. , 1994, JAMA.

[2]  A. Östör,et al.  Natural history of cervical intraepithelial neoplasia: a critical review. , 1993, International Journal of Gynecological Pathology.

[3]  Julian Peto,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[4]  E. Trimble,et al.  Interim Guidelines for Management of Abnormal Cervical Cytology , 1994 .

[5]  J. Fletcher,et al.  A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. , 1995, The American journal of pathology.

[6]  T. Wright,et al.  Precancerous Lesions of the Cervix , 1994 .

[7]  R Reid,et al.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. , 1992, Obstetrics and gynecology.

[8]  B. Oostra,et al.  Trinucleotide repeat polymorphism in the androgen receptor gene (AR). , 1992, Nucleic acids research.

[9]  T. Wright,et al.  Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. , 1992, JAMA.

[10]  R. Richart.  A modified terminology for cervical intraepithelial neoplasia. , 1990, Obstetrics and gynecology.

[11]  T. Wright,et al.  A Polymerase Chain Reaction–Enzyme‐Linked Immunosorbent Assay Method for Detecting Human Papillomavirus in Cervical Carcinomas and High‐Grade Cervical Cancer Precursors , 1995, Obstetrics and gynecology.

[12]  D. Townsend,et al.  Genetic variants of glucose‐6‐phosphate dehydrogenase in the study of carcinoma of the cervix , 1971, Cancer.

[13]  B. Vogelstein,et al.  Clonal origin of bladder cancer. , 1992, The New England journal of medicine.

[14]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[15]  T. Wright,et al.  Controversies in the management of low‐grade cervical intraepithelial neoplasia , 1993, Cancer.

[16]  J. Koulos,et al.  Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas. , 1993, Gynecologic oncology.

[17]  T. Wright,et al.  Comparison of Management Algorithms for the Evaluation of Women With Low‐Grade Cytologic Abnormalities , 1995, Obstetrics and gynecology.

[18]  T. Wright,et al.  Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. , 1992, Molecular and cellular probes.

[19]  J. Sklar,et al.  Clonal analysis by study of X chromosome inactivation in formalin-fixed paraffin-embedded tissue. , 1994, Cancer research.

[20]  P. Fialkow,et al.  Clonal origin of human tumors. , 1979, Annual review of medicine.